Pharmacological Characterization of Diethyl-2-({3-dimethylcarbamoyl-4-[(4′-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein-Reference-Cited by-同舟云学术

Pharmacological Characterization of Diethyl-2-({3-dimethylcarbamoyl-4-[(4′-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein

Published:2010-10-25 Issue:2 Volume:336 Page:321-327
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Mera Yasuko,Odani Naoya,Kawai Takashi,Hata Takahiro,Suzuki Masahiro,Hagiwara Atsushi,Katsushima Takeo,Kakutani Makoto

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference24 articles.

1. JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs

2. MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?

3. CP-346086

4. The cholesterol/saturated-fat index: an indication of the hypercholesterolaemic and atherogenic potential of food;Connor;Lancet,1986

5. Guinea pigs as models for cholesterol and lipoprotein metabolism;Fernandez;J Nutr,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acyl-CoA:diacylglycerol acyltransferase 1 inhibition in the small intestine increases plasma transaminase activity via the activation of protein kinase C pathway;The Journal of Toxicological Sciences;2022

2. PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport;Journal of Biological Chemistry;2021-01

3. Role of the Gut in Diabetic Dyslipidemia;Frontiers in Endocrinology;2020-03-13

4. Investigational therapies for hypercholesterolemia;Expert Opinion on Investigational Drugs;2017-04-13

5. Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia;Critical Reviews in Clinical Laboratory Sciences;2016-10